{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:29:14Z","timestamp":1788607754060,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.berh.2024.101977","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:17:46Z","timestamp":1722385066000},"page":"101977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biology of HLA class I associated inflammatory diseases"],"prefix":"10.1016","volume":"38","author":[{"given":"Ali","family":"Bordbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Manches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Nowatzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"D1","key":"10.1016\/j.berh.2024.101977_bib1","doi-asserted-by":"crossref","first-page":"D1053","DOI":"10.1093\/nar\/gkac1011","article-title":"The IPD-IMGT\/HLA database","volume":"51","author":"Barker","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.berh.2024.101977_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","article-title":"The MHC locus and genetic susceptibility to autoimmune and infectious diseases","volume":"18","author":"Matzaraki","year":"2017","journal-title":"Genome Biol"},{"issue":"7681","key":"10.1016\/j.berh.2024.101977_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature24627","article-title":"Structure of the human MHC-I peptide-loading complex","volume":"551","author":"Blees","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.berh.2024.101977_bib4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4049\/jimmunol.157.5.1823","article-title":"Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?","volume":"157","author":"Yewdell","year":"1996","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.berh.2024.101977_bib5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00018-011-0657-y","article-title":"The role of the proteasome in the generation of MHC class I ligands and immune responses","volume":"68","author":"Sijts","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.berh.2024.101977_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1074-7613(03)00051-7","article-title":"Quantitating protein synthesis, degradation, and endogenous antigen processing","volume":"18","author":"Princiotta","year":"2003","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.berh.2024.101977_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0952-7915(94)90030-2","article-title":"Peptide selection by mhc-encoded tap transporters","volume":"6","author":"Momburg","year":"1994","journal-title":"Curr Opin Immunol"},{"issue":"13","key":"10.1016\/j.berh.2024.101977_bib8","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.berh.2024.101977_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.jid.5700118","article-title":"Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients","volume":"126","author":"Gudjonsson","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"14","key":"10.1016\/j.berh.2024.101977_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.berh.2024.101977_bib11","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1093\/hmg\/ddu307","article-title":"A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy","volume":"23","author":"Kuiper","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.berh.2024.101977_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/09273948.2011.634978","article-title":"HLA-B*51 and behcet disease","volume":"20","author":"Gul","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.berh.2024.101977_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7941","key":"10.1016\/j.berh.2024.101977_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","article-title":"Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides","volume":"612","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.berh.2024.101977_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3389\/fimmu.2018.00954","article-title":"Human leukocyte antigen-class I alleles and the autoreactive T cell response in psoriasis pathogenesis","volume":"9","author":"Prinz","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.berh.2024.101977_bib16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard-2022-222277","article-title":"The Beh\u00e7et's disease risk-variant HLA-B51\/ERAP1-Hap10 alters human CD8 T cell immunity","volume":"81","author":"Cavers","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2024.101977_bib17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1074\/mcp.RA119.001515","article-title":"Redundancy and complementarity between ERAP1 and ERAP2 revealed by their effects on the behcet's disease-associated HLA-B*51 peptidome","volume":"18","author":"Guasp","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.berh.2024.101977_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.berh.2024.101977_bib19","article-title":"How ERAP1 and ERAP2 shape the peptidomes of disease-associated MHC-I proteins","volume":"9","author":"de Castro","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molimm.2015.07.010","article-title":"Effects of polymorphic variation on the mechanism of endoplasmic reticulum aminopeptidase 1","volume":"67","author":"Stamogiannos","year":"2015","journal-title":"Mol Immunol"},{"issue":"24","key":"10.1016\/j.berh.2024.101977_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249608","article-title":"The impact of the 'mis-peptidome' on HLA class I-mediated diseases: contribution of ERAP1 and ERAP2 and effects on the immune response","volume":"21","author":"Tedeschi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.berh.2024.101977_bib22","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1074\/jbc.M117.789180","article-title":"The Behcet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing","volume":"292","author":"Guasp","year":"2017","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.39430","article-title":"The peptidome of behcet's disease-associated HLA-B*51:01 includes two subpeptidomes differentially shaped by endoplasmic reticulum aminopeptidase 1","volume":"68","author":"Guasp","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"47","key":"10.1016\/j.berh.2024.101977_bib24","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1073\/pnas.0500721102","article-title":"The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a \"molecular ruler\" mechanism","volume":"102","author":"Chang","year":"2005","journal-title":"P Natl Acad Sci USA"},{"issue":"6906","key":"10.1016\/j.berh.2024.101977_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature01074","article-title":"ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum","volume":"419","author":"Serwold","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.berh.2024.101977_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ni1286","article-title":"The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules","volume":"7","author":"Hammer","year":"2006","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.berh.2024.101977_bib27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ni860","article-title":"The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues","volume":"3","author":"York","year":"2002","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.berh.2024.101977_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.immuni.2006.09.012","article-title":"ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum","volume":"25","author":"Kanaseki","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2024.101977_bib29","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171503","article-title":"The role of polymorphic ERAP1 in autoinflammatory disease","volume":"38","author":"Reeves","year":"2018","journal-title":"Bioscience Rep"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.berh.2024.101977_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.berh.2024.101977_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2024.101977_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molimm.2016.08.005","article-title":"Molecular and pathogenic effects of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in MHC-I-associated inflammatory disorders: towards a unifying view","volume":"77","author":"Lopez de Castro","year":"2016","journal-title":"Mol Immunol"},{"key":"10.1016\/j.berh.2024.101977_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.38249","article-title":"Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27","volume":"66","author":"Chen","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2024.101977_bib36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.berh.2024.101977_bib37","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/annrheumdis-2015-207416","article-title":"ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients","volume":"74","author":"Robinson","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"10.1016\/j.berh.2024.101977_bib38","first-page":"4333","article-title":"Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(Birdshot) Uveitis","volume":"27","author":"Kuiper","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"49","key":"10.1016\/j.berh.2024.101977_bib39","doi-asserted-by":"crossref","first-page":"17594","DOI":"10.1073\/pnas.1408882111","article-title":"Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis","volume":"111","author":"Reeves","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"52","key":"10.1016\/j.berh.2024.101977_bib40","doi-asserted-by":"crossref","first-page":"26709","DOI":"10.1073\/pnas.1912070116","article-title":"Mechanism for antigenic peptide selection by endoplasmic reticulum aminopeptidase 1","volume":"116","author":"Giastas","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.berh.2024.101977_bib41","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/art.39072","article-title":"ERAP1 gene expression is influenced by nonsynonymous polymorphisms associated with predisposition to spondyloarthritis","volume":"67","author":"Costantino","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.40369","article-title":"Genetic variants in ERAP1 and ERAP2 associated with immune-mediated diseases influence protein expression and the isoform profile","volume":"70","author":"Hanson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101977_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fimmu.2017.00946","article-title":"The role of conformational dynamics in antigen trimming by intracellular aminopeptidases","volume":"8","author":"Papakyriakou","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.berh.2024.101977_bib44","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4049\/jimmunol.1200918","article-title":"A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing","volume":"189","author":"Evnouchidou","year":"2012","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.berh.2024.101977_bib45","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/2326-6066.CIR-18-0498","article-title":"HPV epitope processing differences correlate with ERAP1 allotype and extent of CD8(+) T-cell tumor infiltration in OPSCC","volume":"7","author":"Reeves","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.berh.2024.101977_bib46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jhep.2019.01.034","article-title":"ERAP1 allotypes shape the epitope repertoire of virus-specific CD8(+) T cell responses in acute hepatitis C virus infection","volume":"70","author":"Kemming","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.berh.2024.101977_bib47","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.0903712","article-title":"Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells","volume":"184","author":"Blanchard","year":"2010","journal-title":"J Immunol"},{"issue":"24","key":"10.1016\/j.berh.2024.101977_bib48","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.0603095103","article-title":"Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance","volume":"103","author":"York","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/art.42327","article-title":"Paradoxical effects of endoplasmic reticulum aminopeptidase 1 deficiency on HLA-B27 and its role as an epistatic modifier in experimental spondyloarthritis","volume":"75","author":"Tran","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2024.101977_bib50","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.4049\/jimmunol.163.12.6665","article-title":"Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies","volume":"163","author":"Mear","year":"1999","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.berh.2024.101977_bib51","doi-asserted-by":"crossref","first-page":"23459","DOI":"10.1074\/jbc.M110336200","article-title":"HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum","volume":"277","author":"Dangoria","year":"2002","journal-title":"J Biol Chem"},{"issue":"7681","key":"10.1016\/j.berh.2024.101977_bib52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"Luksza","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.berh.2024.101977_bib53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/ard-2022-222852","article-title":"EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders","volume":"82","author":"Kuiper","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101977_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"issue":"6015","key":"10.1016\/j.berh.2024.101977_bib55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science."},{"key":"10.1016\/j.berh.2024.101977_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104055","article-title":"Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies","volume":"80","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.berh.2024.101977_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105684","article-title":"HLA-B27 and human beta2-microglobulin affect the gut microbiota of transgenic rats","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.07.014","article-title":"Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site","volume":"43","author":"Horai","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.berh.2024.101977_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00389-21","article-title":"Genetic susceptibility to enteric fever in experimentally challenged human volunteers","volume":"90","author":"Barton","year":"2022","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.berh.2024.101977_bib60","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.immuni.2022.08.016","article-title":"The CD4(+) T cell response to a commensal-derived epitope transitions from a tolerant to an inflammatory state in Crohn's disease","volume":"55","author":"Pedersen","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2024.101977_bib61","article-title":"Immunogenic self-peptides - the great unknowns in autoimmunity: identifying T-cell epitopes driving the autoimmune response in autoimmune diseases","volume":"13","author":"Prinz","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.berh.2024.101977_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acs.jmedchem.9b00293","article-title":"Discovery of selective inhibitors of endoplasmic reticulum aminopeptidase 1","volume":"63","author":"Maben","year":"2020","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.berh.2024.101977_bib63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cpt.2343","article-title":"Immunopharmacogenomics: mechanisms of HLA-associated drug reactions","volume":"110","author":"Deshpande","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"10.1016\/j.berh.2024.101977_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115177","article-title":"Exploration of zinc-binding groups for the design of inhibitors for the oxytocinase subfamily of M1 aminopeptidases","volume":"27","author":"Tsoukalidou","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"39","key":"10.1016\/j.berh.2024.101977_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202203560","article-title":"Discovery of the first selective nanomolar inhibitors of ERAP2 by kinetic target-guided synthesis","volume":"61","author":"Camberlein","year":"2022","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.berh.2024.101977_bib66","article-title":"553 First-in-class inhibitors of ERAP1 alter the immunopeptidome of cancer, driving a differentiated T cell response leading to tumor growth inhibition","author":"Joyce","year":"2021","journal-title":"BMJ Specialist Journals"},{"key":"10.1016\/j.berh.2024.101977_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2014.08.007","article-title":"Regulating adaptive immune responses using small molecule modulators of aminopeptidases that process antigenic peptides","volume":"23","author":"Stratikos","year":"2014","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.berh.2024.101977_bib68","article-title":"Modulators of hERAP2 discovered by high-throughput screening","volume":"211","author":"Laura","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"19","key":"10.1016\/j.berh.2024.101977_bib69","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1021\/acs.jmedchem.6b01031","article-title":"Optimization and structure-activity relationships of phosphinic pseudotripeptide inhibitors of aminopeptidases that generate antigenic peptides","volume":"59","author":"Kokkala","year":"2016","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.berh.2024.101977_bib70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","article-title":"Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations","volume":"132","author":"Campbell","year":"2011","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.berh.2024.101977_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195778","article-title":"Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population","volume":"13","author":"Saito","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.berh.2024.101977_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/art.22295","article-title":"HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease","volume":"56","author":"Turner","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2024.101977_bib73","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.4049\/jimmunol.157.8.3350","article-title":"Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells","volume":"157","author":"Peruzzi","year":"1996","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.berh.2024.101977_bib74","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1002\/art.21395","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"21","key":"10.1016\/j.berh.2024.101977_bib75","doi-asserted-by":"crossref","first-page":"11636","DOI":"10.1073\/pnas.1920570117","article-title":"The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function","volume":"117","author":"Saunders","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.berh.2024.101977_bib76","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/0008-5472.CAN-14-1643","article-title":"ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors","volume":"75","author":"Cifaldi","year":"2015","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.berh.2024.101977_bib77","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-10-3326","article-title":"Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing","volume":"71","author":"Cifaldi","year":"2011","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.berh.2024.101977_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008906","article-title":"Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis","volume":"16","author":"Hanson","year":"2020","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.berh.2024.101977_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000597","article-title":"Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis","volume":"4","author":"Cauli","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.101977_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.599558","article-title":"HLA-A29 and birdshot uveitis: further down the rabbit hole","volume":"11","author":"Kuiper","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.101977_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634441","article-title":"ERAP2 increases the abundance of a peptide submotif highly selective for the birdshot uveitis-associated HLA-A29","volume":"12","author":"Venema","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.berh.2024.101977_bib82","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jid.2019.12.006","article-title":"The interaction of LILRB2 with HLA-B is associated with psoriasis susceptibility","volume":"140","author":"Yanovsky","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2024.101977_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004196","article-title":"LILRB2 interaction with HLA class I correlates with control of HIV-1 infection","volume":"10","author":"Bashirova","year":"2014","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.berh.2024.101977_bib84","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nsmb.2021","article-title":"Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1","volume":"18","author":"Nguyen","year":"2011","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10.1016\/j.berh.2024.101977_bib85","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.it.2011.08.001","article-title":"DRiPs solidify: progress in understanding endogenous MHC class I antigen processing","volume":"32","author":"Yewdell","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.berh.2024.101977_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"Hla-B27","volume":"33","author":"Bowness","year":"2015","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"10.1016\/j.berh.2024.101977_bib87","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.4049\/jimmunol.162.10.5680","article-title":"Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection","volume":"162","author":"Plas","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.berh.2024.101977_bib88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4419-0298-6_16","article-title":"HLA-B27 misfolding and spondyloarthropathies","volume":"649","author":"Colbert","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"10.1016\/j.berh.2024.101977_bib89","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/art.10605","article-title":"Cell-surface expression and immune receptor recognition of HLA-B27 homodimers","volume":"46","author":"Kollnberger","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2024.101977_bib90","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.173.3.1699","article-title":"HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors","volume":"173","author":"Kollnberger","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.berh.2024.101977_bib91","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.13020","article-title":"The interplay between HLA-B27 and ERAP1\/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis","volume":"190","author":"Vitulano","year":"2017","journal-title":"Clin Exp Immunol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T13:14:38Z","timestamp":1725110078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1521694224000482"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101977","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biology of HLA class I associated inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101977"}}